Is There Anything Driving The bioAffinity Technologies (BIAF) Stock Up?

The shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) rose 36.96% to $5.67 on Wednesday after the company announced the publication of its research. At the end of the previous trading session, the stock of BIAF closed at $4.14. Its shares ranged between $4.06 and $4.56.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored


BIAF has announced which publication?

Today, bioAffinity Technologies (BIAF) announced the publication of its sputum flow cytometry research. Sputum analysis by flow cytometry; an effective platform to analyze the lung environment; published in PLOS ONE, reported results of high-throughput diagnostic tests to determine the health of the lungs based on sputum analysis by flow cytometry.

  • As a result of the PLOS ONE article, BIAF was able to present its unique method for detecting lung disease among individuals.
  • By using flow cytometry, it is possible to analyze whole cells and populations of cells that make up the lung environment.
  • Research conducted by BIAF has allowed it to better understand how the disease affects the lungs and how flow cytometry can be used to diagnose lung diseases.
  • It is possible to diagnose blood cancer, especially at an early stage, with flow cytometry.
  • An innovative and highly efficient method of analyzing sputum for lung cancer is described in the paper, which could be used to analyze other diseases such as COPD and asthma as well.

What else BIAF has been developing?

In addition to developing non-invasive cancer diagnostics and targeted cancer treatment, bioAffinity Technologies addresses the need for early-stage cancer diagnosis and lung disease treatment. With proprietary noninvasive diagnostic tests developed by BIAF, cancer cells and cells indicative of disease can be identified by using technology that preferentially targets cancer cells. CyPath Lung, the company’s first product, is a non-invasive test that can detect early-stage lung cancer with high sensitivity and specificity. In this case, Precision Pathology Services is marketing the test as a Laboratory Developed Test (LDT). At The University of Texas at San Antonio, the Company’s platform technologies are researched and optimized.

What happened recently?

bioAffinity Technologies (BIAF) recently announced the successful completion of its previously announced initial public offering (IPO) of 1,282,600 shares. In the offering, one share of common stock and one warrant for the purchase of one share of common stock was sold for $7.35 each. In addition, it provided a non-tradable warrant for the purchase of one share of common stock at an exercise price of $7.656 per share. The IPO of BIAF generated approximately $7.8 million in gross proceeds.

Latest

On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...

Newsletter

 

Don't miss

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

5 Best TaaS Stocks to Buy Right Now

TaaS stock refers to a financial asset sold by...

Investors must take note of American Airlines Group Inc.’s (AAL) performance last week, which was 0.55%.

American Airlines Group Inc. (NASDAQ: AAL) on January 27, 2023, started off the session at the price of $16.535, plunging -1.08% from the previous...

Lincoln National Corporation (LNC) with a beta value of 1.76 appears to be a promising investment opportunity.

January 27, 2023, Lincoln National Corporation (NYSE: LNC) trading session started at the price of $33.10, that was 3.63% jump from the session before....

Now that Comstock Inc.’s volume has hit 0.55 million, investors get a glimpse of its size.

On January 27, 2023, Comstock Inc. (AMEX: LODE) opened at $0.53, higher 5.65% from the last session. During the day, the shares moved up...

LEAVE A REPLY

Please enter your comment!
Please enter your name here